摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2R,3S,4R,5R,6R)-6-((S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanamido)-5-acetamido-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl diacetate | 154395-61-6

中文名称
——
中文别名
——
英文名称
(2R,3S,4R,5R,6R)-6-((S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanamido)-5-acetamido-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl diacetate
英文别名
Nω-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl-Nα-(9-fluorenylmethyloxycarbonyl))-L-asparagine tert-butyl ester;N-α-fluorenylmethoxycarbonyl-N-γ-(2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-β-D-glucopyranosyl)-L-asparagine tert-butyl ester;N-α-fluorenylmethoxycarbonyl-N-β-(2-N-acetylamido-2-deoxy-β-D-glucopyranosyl)-2-tert-butoxy-L-asparagine;tert-butyl (2S)-4-[[(2R,3R,4R,5S,6R)-3-acetamido-4,5-diacetyloxy-6-(acetyloxymethyl)oxan-2-yl]amino]-2-(9H-fluoren-9-ylmethoxycarbonylamino)-4-oxobutanoate
(2R,3S,4R,5R,6R)-6-((S)-3-((((9H-fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanamido)-5-acetamido-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl diacetate化学式
CAS
154395-61-6
化学式
C37H45N3O13
mdl
——
分子量
739.777
InChiKey
LCBFPOZEMMSKAF-GBBYZUMQSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    918.2±65.0 °C(Predicted)
  • 密度:
    1.32±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.3
  • 重原子数:
    53
  • 可旋转键数:
    18
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.49
  • 拓扑面积:
    211
  • 氢给体数:
    3
  • 氢受体数:
    13

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • Site-Selective Chemoenzymatic Glycosylation of an HIV-1 Polypeptide Antigen with Two Distinct N-Glycans via an Orthogonal Protecting Group Strategy
    作者:Christian Toonstra、Mohammed N. Amin、Lai-Xi Wang
    DOI:10.1021/acs.joc.6b01044
    日期:2016.8.5
    glycosynthase-catalyzed transglycosylation reactions. It was observed that the protecting groups on one neighboring GlcNAc moiety have an impact on the substrate activity of another GlcNAc acceptor toward some endoglycosynthases in transglycosylation. The usefulness of this synthetic strategy was exemplified by an efficient synthesis of the glycopeptide neutralizing epitope of broadly HIV-neutralizing antibody
    描述了用于在多肽中顺序安装不同N-聚糖的会聚化学酶法。该方法包括在自动固相肽合成(SPPS)期间引入区别保护的GlcNAc-Asn构建基块,然后通过糖合酶催化的转糖基化反应对GlcNAc引物进行正交保护,并进行糖链的位点选择性顺序延伸。观察到一个相邻的GlcNAc部分上的保护基在转糖基化中对另一种GlcNAc受体对某些内切糖合酶的底物活性有影响。有效合成广泛中和HIV的抗体PG9的糖肽中和表位证明了这种合成策略的实用性。
  • Improving Selectivity, Proteolytic Stability, and Antitumor Activity of Hymenochirin-1B: A Novel Glycosylated Staple Strategy
    作者:Yulei Li、Yihan Zhang、Minghao Wu、Qi Chang、Honggang Hu、Xia Zhao
    DOI:10.1021/acschembio.9b00046
    日期:2019.3.15
    glycosylation strategy. Some analogues showed improvement not only in selectivity and proteolytic stability but also in antitumor activity. Among them, the glycosylated stapled peptide H-58 was identified as the most potential antitumor peptide. Flow cytometry and a competitive binding assay revealed that H-58 displayed significant antitumor selectivity. Confocal microscopy and nuclear staining with Hoechst
    作为宿主防御肽,hymenochirin-1B因其强大的细胞毒活性而受到越来越多的关注。但是,其差的选择性和蛋白解稳定性仍然是临床应用的主要障碍。为了解决这些问题,我们基于阳离子残基取代和装订结合糖基化策略设计并合成了膜联膜蛋白-1B的一系列肽类似物。一些类似物不仅显示出选择性和蛋白解稳定性的改善,而且还显示出抗肿瘤活性的改善。其中,糖基化固定肽H-58被鉴定为最有潜力的抗肿瘤肽。流式细胞仪和竞争性结合试验表明,H-58表现出显着的抗肿瘤选择性。共焦显微镜检查和Hoechst染料的核染色表明,H-58进入细胞核并造成DNA损伤。总之,糖基化钉书钉肽的策略是一种有前途的方法,用于提高膜球蛋白-1B的抗肿瘤选择性,蛋白解稳定性和抗肿瘤活性,该膜可用于其他生物活性肽修饰。
  • Novel sequential solid-phase synthesis of N-linked glycopeptides from natural sources
    作者:Ernst Meinjohanns、Morten Meldal、Hans Paulsen、Raymond A. Dwek、Klaus Bock
    DOI:10.1039/a705528e
    日期:——
    In the present report a practical and versatile procedure for the solid-phase synthesis of N-linked glycopeptides from natural sources has been demonstrated. The approach is based on the mild hydrazinolysis procedure to release N-linked oligosaccharides in their intact unreduced form from the natural glycoproteins, e.g. fetuin and ribonuclease B and subsequent formation of the corresponding glycosylamines. Treatment of the reducing sugars 1–7 with a saturated solution of ammonium hydrogen carbonate in either water or dimethyl sulfoxide (DMSO) gives in almost quantitative yields the glycosylamines 8–14. Coupling of the unprotected glycosylamines 8–14 to the side-chain-activated aspartic acid derivative Fmoc-Asp(ODhbt)-OBut 16 affords the N-glycosylated asparagine derivatives 17–23. Subsequent acetylation of the carbohydrate hydroxy groups and cleavage of the tert-Bu ester by trifluoroacetic acid (TFA) treatment yields the glycosylated N-linked building blocks 31–37. The building blocks 31–37 are then incorporated into the multiple-column peptide-synthesis protocol of the glycopeptide T-cell epitope analogues 40–46 of the mouse haemoglobin-derived decapeptide Hb (67–76), VITAFNEGLK. The decapeptide sequence VITAFNEGLK binds well to the MHC Class II Ek molecule and is non-immunogenic in CBA/J mice. Syntheses of several natural and unnatural glycosylations, e.g. N-acetylglucosamine, N,N′-diacetylchitobiose, glucose, maltotriose, maltoheptose and di- and tri-antennary complex oligosaccharides on the decapeptide Hb (67–76) affording the N-linked glycopeptides 40–46 are described. The N-linked glycopeptides 40–46 have been fully characterised by 1D- and 2D-1H and 13C NMR spectroscopy and by ES-MS.
    本报告展示了一种从天然来源固相合成 N-连接糖肽的实用且多功能的方法。该方法基于温和的解程序,以完整的未还原形式从天然糖蛋白(如胎盘素和核糖核酸酶 B)中释放出 N-连接寡糖,随后形成相应的糖基胺。用碳酸氢铵二甲基亚砜DMSO)中的饱和溶液处理还原糖 1-7,几乎可以得到定量的糖基胺 8-14。将未受保护的糖基胺 8-14 与侧链激活的天冬氨酸生物 Fmoc-Asp(ODhbt)-OBut 16 偶联,可得到 N-糖基化的天冬酰胺生物 17-23。随后通过三氟乙酸(TFA)处理对碳水化合物羟基进行乙酰化并裂解叔丁,可得到糖基化的 N-连接构筑模块 31-37。然后,将这些结构单元 31-37 加入小鼠血红蛋白衍生的十肽 Hb(67-76)VITAFNEGLK 的糖肽 T 细胞表位类似物 40-46 的多柱肽合成方案中。十肽序列 VITAFNEGLK 与 MHC II 类 Ek 分子结合良好,对 CBA/J 小鼠无免疫原性。本文介绍了在十肽 Hb(67-76)上进行几种天然和非天然糖基化,如 N-乙葡糖胺、N,N′-二乙酰寡糖葡萄糖麦芽三糖、麦芽庚糖以及二元和三元泛酰复合寡糖,从而得到 N-连接的糖肽 40-46。通过 1D- 和 2D-1H 和 13C NMR 光谱以及 ES-MS 对 N-连接的糖肽 40-46 进行了全面鉴定。
  • Native N-glycopeptide thioester synthesis through N→S acyl transfer
    作者:Bhavesh Premdjee、Anna L. Adams、Derek Macmillan
    DOI:10.1016/j.bmcl.2011.05.059
    日期:2011.9
    Peptide thioesters are important tools for the total synthesis of proteins using native chemical ligation (NCL). Preparation of glycopeptide thioesters, that enable the assembly of homogeneously glycosylated proteins, is complicated by the perceived fragile nature of the sugar moiety. Herein, we demonstrate the compatibility of thioester formation via N→S acyl transfer with native N-glycopeptides and
    是使用天然化学连接 (NCL) 进行蛋白质全合成的重要工具。糖肽的制备能够组装均匀的糖基化蛋白质,但由于糖部分的脆弱性质而变得复杂。在此,我们证明了通过N → S酰基转移形成的天然N-糖肽的相容性,并报告了有助于其制备的观察结果。
  • A Simple Method for the Synthesis of Nβ-Glycosylated-Asparagine and -Glutamine Derivatives
    作者:Mamoru Mizuno、Ikuyo Muramoto、Katsuaki Kobayashi、Hiroshi Yaginuma、Toshiyuki Inazu
    DOI:10.1055/s-1999-3674
    日期:——
    N β-Glycosylated-asparagine and -glutamine derivatives, which are useful precursors for the synthesis of N-glucopeptides and their analogs, were obtained in good yields by the reaction of a glycosyl azide and an N α-protected-aspartic/glutamic acid α-monoester in the presence of trialkylphosphine at low temperature.
    在三烷基膦存在下,通过糖基叠氮化物与 N δ-保护-天冬氨酸/谷酸 δ-单在低温下的反应,获得了 N δ-糖基化-天冬酰胺和-谷酰胺生物,这些衍生物是合成 N-葡肽及其类似物的有用前体,产量很高。
查看更多

同类化合物

霉酚酸苯酚beta-D-葡糖苷 阜孢霉素B 阜孢杀菌素 蔗糖棕榈酸酯 蔗糖四异硬脂酸酯 蔗糖七月桂酸酯 药喇叭(IPOMOEAPURGA)树脂 纤维素二糖八壬烷酸酯 硫脂I 石斛碱;青藤碱 甲基6-O-(2-十四烷基-3-羟基十八碳酰基)-alpha-D-吡喃葡萄糖苷 环戊羧酸,1-氨基-2-甲基-,(1R,2S)-rel- 特女贞苷 海藻糖6,6'-二甲藻酸酯 海藻糖 6,6'-二山嵛酸酯 水螅毒素 木松香II 木松香I 单岩藻糖基乳糖-N-四糖 二唾液酸乳-N-四糖 乳糖醛酸 乙醋化己二酸双淀粉 中文名称暂缺 β-D-呋喃果糖基-α-D-吡喃葡萄苷二硬脂酸酯 Β-D-呋喃果糖基-Α-D-吡喃葡糖苷十二酸双酯 alpha-D-吡喃葡萄糖苷, 6-O-(1-氧代癸基)-alpha-D-吡喃葡萄糖基, 6-癸酸酯 alpha-D-吡喃葡萄糖基-alpha-D-吡喃葡萄糖苷 6-(3-羟基-2-十四烷基十八烷酸酯) [(3aR,5R,5aR,8aS,8bR)-2,2,7,7-四甲基四氢-3aH-二[1,3]二噁唑并[4,5-b:4',5'-d]吡喃-5-基]甲基丁酸酯(non-preferredname) [(2R,3S,4S,5R,6R)-6-[(2R,3R,4S,5S,6R)-6-(十六烷酰氧基甲基)-3,4,5-三羟基四氢吡喃-2-基]氧基-3,4,5-三羟基四氢吡喃-2-基]甲基十六烷酸酯 [(2R,3S,4S,5R)-3,4-二羟基-2,5-二(羟基甲基)四氢呋喃-2-基][(2R,3S,4S,5R,6S)-3,4,5,6-四羟基四氢吡喃-2-基]甲基2-甲基-4-(2-甲基癸-1-烯-4-基)己二酸酯 [(2R,3R,4S,5R,6R)-6-[[(1R,2R,3R,4R,6R)-2,3-二羟基-5,8-二氧杂双环[4.2.0]辛烷-4-基]氧基]-3,4,5-三羟基四氢吡喃-2-基]甲基3-羟基-2-十四烷基十八烷酸酯 N-乙酰基-硫代胞壁酰-丙氨酰-异谷氨酰胺 N-(O-alpha-D-甘露糖基-(1-3)-O-(O-alpha-D-甘露糖基-(1->3)-O-(alpha-D-甘露糖基-(1-6))-alpha-D-甘露糖基-(1-6))-O-beta-D-甘露糖基-(1->4)-O-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基-(1->4)-2-(乙酰氨基)-2-脱氧-beta-D-吡喃葡萄糖基)-L-天冬氨酰胺 L-缬氨酰-L-丙氨酰-L-缬氨酰甘氨酰-L-α-谷氨酰-L-α-谷氨酰-L-脯氨酰甘氨酰-L-脯氨酰-N~5~-(二氨基甲亚基)-L-鸟氨酸酰胺 D-甘露糖基-(1-6)-D-甘露糖基-(1-4)-2-乙酰氨基-2-脱氧-D-吡喃葡萄糖基-(1-4)-2-乙酰氨基-1-N-(4'-L-天冬氨酰)-2-脱氧-beta-D-吡喃葡萄糖基胺 D-吡喃葡糖酐-2,6-双油酸酯与聚环氧乙烷(2:1)的醚化物 D-(+)-海藻糖6-单油酸酯 9,10-二氯-2,6-二甲基蒽 8-甲氧基羰基辛基2-O-(aL-呋喃基呋喃糖基)-3-O-(aD-吡喃半乳糖基)-bD-吡喃半乳糖苷 6-山慈菇甙A 6-O-alpha-D-吡喃半乳糖基-D-葡萄糖酸 6,6'-二((2R,3R)-3-羟基-2-十四烷基十八烷酸酯)-海藻糖 4H-吡咯并[3,2,1-脱]蝶啶,5,6-二氢-4,5-二甲基-(9CI) 4-嘧啶甲腈,2-苯基- 4-[[(2R)-2-羟基-3,3-二甲基-4-[(2R,3R,4S,5S,6R)-3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基丁酰基]氨基]丁酸 4-[6-(1,2-二羟基乙基)-3,4,5-三羟基-四氢吡喃-2-基]氧基-2,3,5-三羟基-7,8-二氧代-辛酸 3-O-棕榈酰-beta-D-呋喃果糖基2,3-二-O-棕榈酰-alpha-D-吡喃葡萄糖苷 3-(6H-苯并[b][1,5]苯并噁噻庚英-6-基)丙基-二甲基-铵2-羟基-2-羰基-乙酸酯 2-脱氧-3-O-[(3R)-3-羟基十四烷酰基]-2-{[(3R)-3-羟基十四烷酰基]氨基}-1-O-膦酰-alpha-D-吡喃葡萄糖 2-氨基-6-[[3,5,6-三羟基-2-氧代-4-[3,4,5-三羟基-6-(羟基甲基)四氢吡喃-2-基]氧基己基]氨基]己酸